Singapore Markets closed

Augmedix, Inc. (AUGX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.7200+0.0300 (+1.78%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 33.1700
52-week low 31.0100
50-day moving average 31.6307
200-day moving average 31.5553

Share statistics

Avg vol (3-month) 366.83k
Avg vol (10-day) 344.5k
Shares outstanding 537.43M
Implied shares outstanding 6N/A
Float 816.38M
% held by insiders 110.77%
% held by institutions 170.26%
Shares short (30 Jan 2023) 431.48k
Short ratio (30 Jan 2023) 40.27
Short % of float (30 Jan 2023) 40.22%
Short % of shares outstanding (30 Jan 2023) 40.08%
Shares short (prior month 29 Dec 2022) 431k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin -85.24%
Operating margin (ttm)-76.40%

Management effectiveness

Return on assets (ttm)-48.82%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)28.76M
Revenue per share (ttm)0.78
Quarterly revenue growth (yoy)39.80%
Gross profit (ttm)10.01M
EBITDA -21.2M
Net income avi to common (ttm)-24.52M
Diluted EPS (ttm)-0.6070
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)26.25M
Total cash per share (mrq)0.7
Total debt (mrq)17.07M
Total debt/equity (mrq)264.56
Current ratio (mrq)2.07
Book value per share (mrq)-0.26

Cash flow statement

Operating cash flow (ttm)-17.67M
Levered free cash flow (ttm)-11.51M